retatrutide triple agonist gip glp-1 glucagon phase 3 2025 Retatrutide, a agonist, delivered 30.3% weight loss at two years in 3. The headlines state: → 70 lbs average loss on 12mg at 80 weeks (28.3% of body weight) → From Obesity to Metabolic Health:

They work by imitating glucagon-like peptide-1 (GLP-1), a growth hormone that triggers insulin release, reduces blood sugar levels, slows the passage of food along the intestinal tract and stimulates parts of the brain that control craving and satiety

Instead of your body doing this for a short time after eating, this medication helps you feel fuller for longer periods, with just a once-a-week injection

Adequate vitamin D (targeting serum 25-OH D at least 40 ng/mL) supports intestinal calcium absorption and keeps PTH suppressed, protecting bone during the remodeling phase

Lesions on the scalp or face can be associated with asymmetrical growth of scalp hair or beard

You want it to be a bit more gradual